Seeking Alpha

Medgenics (MDGN -7.3%) slips after pricing its offering of company stock and warrants at $5.25,...

Medgenics (MDGN -7.3%) slips after pricing its offering of company stock and warrants at $5.25, near current levels. The company says it's bundling the shares and warrants together, with each unit sold at $5.25 consisting of one share of common stock and a warrant to purchase one-half of a share at an initial exercise price of $6.78. The medical technology and therapeutics company said it plans to sell 5.6M shares of stock in order to raise around $29.4M. Maxim Group is acting as sole book-running manager.
Comments (1)
  • Ltcarr
    , contributor
    Comment (1) | Send Message
     
    I have high hopes for the stock & success of this company. Does
    anyone understand why the price has come down drastically, and if there is confidence that it will shoot up again this year?
    8 Feb 2013, 01:57 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs